Clinical Trial Update: Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Endostar with induction chemotherapy followed by concurrent chemoradiotherapy for locoregional nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN